CATX Perspective Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
15:58
Sep 08
Sep 08
CATX ESMO data with strong cash runway
Author calls CATX his favourite with updated Phase 1/2a data at ESMO Oct 23-27, $237M cash vs $357M cap, 33 months runway, 24% short and 18 days to cover.
MED
00:29
Feb 24
Feb 24
Watch CATX on therapeutic isotope supply scaling.
Watch CATX as increased industry investment and scaling in therapeutic isotopes reduces long-term supply risk for targeted radiotherapies.
MED
About CATX Investor Commentary
Across the available history and selected sources, Buzzberg tracks CATX (Perspective Therapeutics, Inc.) across 2 sources: 0 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/Avish_Golakiya, TheValueist.